Andere talen Ildong Holdings Co., Ltd.

Aandelen

A000230

KR7000230003

slotkoers Korea S.E. Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8.790 ^KRW	-0,11%		+1,03%	-16,44%

14/03	Ildong Holdings Co, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Ildong Holdings Co, Ltd. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Ildong Holdings Co., Ltd.(KOSE:A000230) dropped from S&P Global BMI Index	18-09-23
Ildong Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Shionogi & Co., Ltd. - New Drug Application of Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19 Accepted for Review in South Korea	05-01-23
Idience Co., Ltd announced that it has received KRW 14.9949886 billion in funding from Ildong Holdings Co., Ltd.	30-12-22
Idience Co., Ltd announced that it expects to receive KRW 14.9949886 billion in funding from Ildong Holdings Co., Ltd.	21-12-22
Ildong Holdings Co., Ltd. announced that it has received KRW 30 billion in funding	30-11-22
Ildong Holdings Co., Ltd. announced that it expects to receive KRW 30 billion in funding	15-11-22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
Ildong Holdings Co., Ltd.(KOSE:A000230) added to S&P Global BMI Index	19-09-22
Execution of Sub-license Agreement from Ping An-Shionogi Hong Kong to Ildong for Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19, for South Korea	16-09-22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16-08-22
Twist Bioscience, Ildong Pharmaceutical Partner to Discover Antibodies for Immuno-Oncology	30-06-22
Idience Co., Ltd announced that it expects to receive KRW 15.0050118 billion in funding from Ildong Holdings Co., Ltd., Yuanta Investment, Kiwoom Securities Co., Ltd., Investment Arm and other investors	28-06-22
Ildong Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16-05-22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17-03-22
Ildong : Prior Notice on Disclosure of Final Earnings	14-02-22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15-11-21
Ildong Holdings Co., Ltd. acquired 5.18% stake in Ildong Pharmaceutical Co., Ltd. from Il-dong Foods Co. Ltd. and Lee, Keumki for KRW 22.4 billion.	27-02-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ildong Holdings Co., Ltd.

Aandelen

A000230

KR7000230003

Andere talen

Filters